Compare CGTX & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGTX | GMGI |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.5M | 115.8M |
| IPO Year | 2021 | 2008 |
| Metric | CGTX | GMGI |
|---|---|---|
| Price | $1.14 | $0.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 624.0K | 206.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $151,115,532.00 |
| Revenue This Year | N/A | $25.59 |
| Revenue Next Year | N/A | $14.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.50 |
| 52 Week Low | $0.22 | $0.48 |
| 52 Week High | $3.83 | $2.21 |
| Indicator | CGTX | GMGI |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 51.96 |
| Support Level | $1.00 | $0.58 |
| Resistance Level | $1.19 | $0.74 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 80.56 | 72.29 |
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.